Financial Relationships With Ineligible Companies (Formerly Described as Commercial Interests by the ACCME) Within the Last 2 Years:

Constance A. Benson, MD
Dr Benson has served on advisory and data safety monitoring boards for GlaxoSmithKline/ViiV Healthcare, received research grants awarded to her institution from Gilead Sciences, Inc., and serves as a consultant to NDA Partners, LLC. Her spouse has served as a consultant to CytoDyn, AbbVie and Sempra Energy; owns stock options in Antiva Biosciences and CytoDyn; has served on the board for Gilead Sciences, Inc., with payment remitted to his institution; and has served on data and safety monitoring boards for Gilead Sciences, Inc., and VIR. (Updated 04/20/22)

Judith S. Currier, MD
Dr Currier has served on the advisory board for Merck & Co, Inc. (Updated 04/20/22)

Carlos del Rio, MD
Dr Del Rio has served as a scientific advisor for Resverlogix. (Updated 05/23/22)

Donna M. Jacobsen, BS
Ms Jacobsen has no relevant financial affiliations to disclose. (Updated 04/20/22)

Michael S. Saag, MD
Dr Saag has received research grants and support awarded to his institution from Gilead Sciences, Inc and ViiV Healthcare. (Updated 04/20/22)